LAUREN CARRASCO: Open Payments
NPI 1609384965 · KAUFMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,030 in 109 payments from 23 companies in 2025. Trend: 2023 $1,858 · 2024 $1,957 · 2025 $2,030
Food & beverage: $2,030
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $409 |
| AstraZeneca Pharmaceuticals LP | 13 | $246 |
| PFIZER INC. | 9 | $209 |
| Novo Nordisk Inc | 10 | $151 |
| SANOFI-AVENTIS U.S. LLC | 5 | $129 |
| Corcept Therapeutics | 3 | $108 |
| Astellas Pharma US Inc | 6 | $107 |
| Antares Pharma, Inc. | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Abbott Laboratories | 4 | $82 |
Products named: VRAYLAR, AIRSUPRA, TZIELD, ELIQUIS, JARDIANCE, Korlym, Veozah, XYOSTED.
Industry payments across TX — which companies pay providers there.
